Havana, April 22 (RHC) -– The recent visit to Cuba by a trade mission from the U.S. State of New York, headed by Governor Andrew Cuomo, yielded two bilateral accords in the area of health and opened doors for further collaboration.

The accords include the sale in the United States of a Cuban lung cancer vaccine and the introduction of U.S. software programs in the Cuban medical industry.

Shortly before returning to the U.S. on Tuesday, the director of the Roswell Park Cancer Institute of New York, Candace Johnson, said that they had signed a memo of understanding with Havana's Molecular Immunology Center.

Johnson said she was happy to take the Cuban vaccine to her country and begin treating patients, for which they will immediately start with clinical tests.

The other accord was signed between the U.S. Infor High-Tech company and a Cuban enterprise to introduce specialized software programs for the Cuban health sector.

Charles Phillips, an official with the U.S. company, announced that he found a Cuban partner interested in the commercialization of the products and that they will begin efforts to train students in the use of the new technology.

We are surprised at the high level of expertise that exists in Cuba in the area of health technology, said Phillips.

The New York governor organized the trade mission to Cuba as part of his initiative known as “Global New York,” aimed at expanding trade and investment by the business community in that U.S. state.